Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 1 1

Status

Completed 5

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 3Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Neoplasms 1Fatigue 1Castration-Resistant Prostate Carcinoma 1Castration Resistant Metastatic Prostate Cancer 1Carcinoma, Squamous Cell 1Cachexia 1

Interventions

Cyclophosphamide 909Carboplatin 786Paclitaxel 741pembrolizumab 741Bevacizumab 715Cisplatin 707Gemcitabine 621Docetaxel 583Rituximab 558Radiotherapy 546Dexamethasone 510Nivolumab 488Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 357Pemetrexed 336Oxaliplatin 335Cytarabine 334Lenalidomide 327Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 315Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 275

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Has results × testosterone enanthate × Clear all
NCT03516812 2025-09-29

Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer

University of Washington

Phase 2 Completed
36 enrolled 14 charts
Genitourinary

Castration-Resistant Prostate Carcinoma

NCT02090114 2022-06-27

Restore

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
112 enrolled 20 charts
Genitourinary

Prostatic Neoplasms

NCT02286921 2020-11-06

Transformer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
222 enrolled 25 charts
Genitourinary

Castration Resistant Metastatic Prostate Cancer

NCT00878995 2018-03-12

Testosterone for Treating Cachexia in Patients With Squamous Cell Carcinoma

The University of Texas Medical Branch, Galveston

Phase 1 Completed
28 enrolled 55 charts
Gynecologic

Cachexia, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms

NCT00965341 2016-09-13

Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Completed
53 enrolled 8 charts

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡